Optimal Timing of Bisphosphonate Administration in Combination with Samarium-153 Oxabifore in the Treatment of Painful Metastatic Bone Disease

While bisphosphonates are indicated for prevention of skeletal-related events, radionuclide therapy is widely used for treatment of painful bone metastases. Combined radionuclide therapy with bisphosphonates has demonstrated improved effectiveness in achieving bone pain palliation in comparison to m...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Rasulova, Nigora, Lyubshin, Vladimir, Arybzhanov, Dauranbek, Sagdullaev, Sh., Krylov, Valery, Khodjibekov, Marat
Médium: Artigo
Jazyk:Inglês
Vydáno: Medknow Publications & Media Pvt Ltd 2013
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3745627/
https://ncbi.nlm.nih.gov/pubmed/23961250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1450-1147.113939
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky